Inter- and intra-subject variability of nitric oxide levels in leukocyte subpopulations

• Published in: Nitric oxide Vol. 72; pp. 41 - 45
• Main Authors: Maharaj, Sheena, Lu, Kim D., Radom-Aizik, Shlomit, Zaldivar, Frank, Haddad, Fadia, Shin, Hye-Won, Leu, Szu-Yun, Nussbaum, Eliezer, Randhawa, Inderpal, Cooper, Dan M.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 30.01.2018
• Subjects: Adult; Blood Chemical Analysis - methods; Calmodulin - metabolism; Flow Cytometry; Healthy leukocytes; Humans; Inducible nitric oxide; Killer Cells, Natural - drug effects; Killer Cells, Natural - metabolism; Leukocytes - metabolism; Lipopolysaccharides - pharmacology; Male; Middle Aged; Monocytes - drug effects; Monocytes - metabolism; Nitric oxide; Nitric Oxide - analysis; Nitric Oxide - blood; Nitric Oxide - metabolism; Nitric Oxide Synthase Type II - analysis; Nitric Oxide Synthase Type II - metabolism; Subject variability; Time Factors; Flow cytometry; NO; eNOS; DAF-2DA; Healthy leukocytes; Subject variability; MFI; NOS; Nitric oxide; nNOS; iNOS; Inducible nitric oxide; NK
• ISSN: 1089-8603; 1089-8611; 1089-8611
• DOI: 10.1016/j.niox.2017.11.002

Assessment of nitric oxide (NO) dynamics in immune cells, commonly measured using NO surrogates such as inducible nitric oxide synthase (iNOS) rather than NO itself, has been effective in understanding pathophysiology across a wide range of diseases. Although the intracellular measurement of NO is now feasible, many technical issues remain unresolved. The principle aim of our study was to determine the effect of storage time of whole blood on nitric oxide (NO) level expression in leukocytes. This is important because immune cells remain chemically dynamic even after they are removed from the circulation, and the impact of storage time must be known to optimally quantify the effect of a disease or condition on NO dynamics in circulating leukocytes. We measured NO levels using the fluorescent probe, diaminofluorescein (DAF-2DA), and flow cytometry in monocytes, neutrophils, and natural killer cells from healthy subjects immediately after blood draw (Time 0) and 30, 60, and 120 min following the blood draw. There was no significant difference among the 4 study time points in NO (DAF-2) levels, though there was wide intra-subject variability at all time points. Using LPS stimulation, we compared iNOS (the more traditional surrogate marker of NO dynamics) with NO (by DAF-2) in natural killer cells and monocytes and, we found no difference in the response patterns. In summary, we did find that within a 2-hour interval from blood draw to sample processing, there was a remarkably wide intra-subject variability in expression of intracellular NO (DAF-2) in leukocytes of healthy individuals at baseline and over time. The mechanism(s) for these differences are not known but could clearly confound efforts to detect changes in NO metabolism in white blood cells. We speculate that rapid pulsatility of NO could explain the wide variability seen. •No consistent effect of 2-hour storage time on nitric oxide (DAF-2) levels in healthy leukocytes.•Wide variability in nitric oxide (DAF-2) levels in leukocytes from healthy subjects.•No increase in NO (DAF-2) or iNOS detected post LPS stimulation in healthy leukocytes.